|
|
|
Insider
Information: |
Pops Richard F |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
1,301,687 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$38,585,989 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
1,301,687 |
|
|
Total
Value |
$38,585,989 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Neurocrine Biosciences Inc |
NBIX |
Director |
2024-03-13 |
29,512 |
2005-11-23 |
0 |
Premium* |
|
Alkermes Plc |
ALKS |
Director and CEO, Alke... |
2024-02-08 |
1,179,675 |
2011-09-16 |
0 |
Premium* |
|
Epizyme, Inc. |
EPZM |
Director |
2013-05-30 |
60,000 |
|
0 |
Premium* |
|
Acceleron Pharma Inc |
XLRN |
Director |
2019-01-25 |
32,500 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
257 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 11
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2013-05-20 |
4 |
D |
$31.04 |
$119,038 |
D/D |
(3,835) |
429,626 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2013-05-21 |
4 |
D |
$31.98 |
$122,643 |
D/D |
(3,835) |
433,916 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2013-05-17 |
4 |
D |
$31.69 |
$121,563 |
D/D |
(3,836) |
425,336 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2021-02-17 |
4 |
D |
$19.97 |
$77,264 |
D/D |
(3,869) |
774,026 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2020-02-17 |
4 |
D |
$17.77 |
$69,054 |
D/D |
(3,886) |
731,350 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2019-02-26 |
4 |
D |
$33.92 |
$131,847 |
D/D |
(3,887) |
706,703 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2018-11-12 |
4 |
AS |
$103.30 |
$425,893 |
D/D |
(4,123) |
33,636 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2018-11-26 |
4 |
AS |
$91.37 |
$376,790 |
D/D |
(4,124) |
29,512 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2017-02-26 |
4 |
D |
$52.98 |
$249,271 |
D/D |
(4,705) |
614,257 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2019-02-16 |
4 |
D |
$32.54 |
$173,764 |
D/D |
(5,340) |
694,413 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2018-10-29 |
4 |
AS |
$107.13 |
$589,237 |
D/D |
(5,500) |
37,759 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2018-03-03 |
4 |
D |
$60.05 |
$347,029 |
D/D |
(5,779) |
666,352 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2017-03-03 |
4 |
D |
$60.97 |
$372,953 |
D/D |
(6,117) |
630,406 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2015-03-03 |
4 |
D |
$72.80 |
$445,754 |
D/D |
(6,123) |
526,940 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2017-05-28 |
4 |
D |
$57.70 |
$373,319 |
D/D |
(6,470) |
637,686 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2015-05-28 |
4 |
D |
$59.92 |
$388,102 |
D/D |
(6,477) |
542,917 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2014-05-28 |
4 |
D |
$45.74 |
$296,578 |
D/D |
(6,484) |
520,063 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2019-03-01 |
4 |
D |
$34.44 |
$267,599 |
D/D |
(7,770) |
716,433 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2020-03-01 |
4 |
D |
$20.84 |
$161,927 |
D/D |
(7,770) |
759,094 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2018-03-01 |
4 |
D |
$57.41 |
$446,592 |
D/D |
(7,779) |
659,131 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2012-07-05 |
4 |
OE |
$4.77 |
$37,683 |
D/D |
7,900 |
356,073 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2012-07-05 |
4 |
AS |
$18.01 |
$142,309 |
D/D |
(7,900) |
348,173 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2022-02-16 |
4 |
D |
$26.79 |
$215,338 |
D/D |
(8,038) |
847,542 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2020-02-16 |
4 |
D |
$17.77 |
$143,439 |
D/D |
(8,072) |
726,486 |
0 |
- |
|
ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
|
2021-02-16 |
4 |
D |
$19.79 |
$159,784 |
D/D |
(8,074) |
769,145 |
0 |
- |
|
257 Records found
|
|
Page 2 of 11 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|